← Back to Search

Intensive Referral Intervention Group for Smoking Cessation

N/A
Waitlist Available
Led By Kathleen M Grant, MD
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
CBR-MH Probationers in Douglas County, NE
SUD
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

The purpose of this study is to determine if Intensive Referral Intervention increases motivation to quit cigarette smoking and quitting-related behaviors in probationers and also to determine if Intensive Referral Intervention improves short-term substance use outcomes in probationers with substance use disorder.

Eligible Conditions
  • Smoking Cessation
  • Substance Use Disorder

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Motivation measured by Fagerstrom Test
Secondary outcome measures
Change in Timeline Follow-back Calendar
Other outcome measures
Motivation measured by QSU-Brief Questionnaire for Smoking Urges
Motivation measured by Readiness to Quit Ladder

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intensive Referral Intervention GroupExperimental Treatment1 Intervention
Intensive Referral Intervention will by done by trained probation officers
Group II: Standard Practice Facilitated GroupActive Control1 Intervention
Standard Current Practice will be provided by untrained probation officers
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intensive Referral Intervention Group
2016
N/A
~50

Find a Location

Who is running the clinical trial?

University of NebraskaLead Sponsor
536 Previous Clinical Trials
1,143,876 Total Patients Enrolled
Kathleen M Grant, MDPrincipal InvestigatorUniversity of Nebraska
3 Previous Clinical Trials
517 Total Patients Enrolled
Kathleen GrantPrincipal InvestigatorUNMC

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025